Insights

2 highly rated ASX growth shares to buy now

Kogan.com Ltd (ASX:KGN) and this highly rated ASX growth share could be the ones to buy now. Here’s what you need to know…
The post 2 highly rated ASX growth shares to buy now appeared first on The Motley Fool Australia. –

steps to picking asx shares represented by four lightbulbs drawn on chalk board

If you’re a fan of growth shares, then I have good news for you. The Australian share market is home to a good number of companies growing their earnings at a quick rate.

Two ASX growth shares that could be worth a closer look are listed below. Here’s what you need to know about them:

Kogan.com Ltd (ASX: KGN)

The first ASX growth to look at is Kogan. This leading ecommerce company has been growing at a rapid rate in FY 2021 thanks to the accelerating shift to online shopping. And while the rate that it is growing at will inevitably moderate in the near future, its long term outlook remains very positive.

This is thanks to the structural shift online, its growing customer base, acquisitions and expansions, and increasing Exclusive Brands sales. Credit Suisse is very positive on the company. Its analysts currently have an outperform rating and $20.85 price target on its shares. This compares to the current Kogan share price of $12.47.

Pro Medicus Limited (ASX: PME)

Another growth share to look at is Pro Medicus. It is a leading provider of radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualisation solutions. The company notes that it provides products and services that combine speed, scalability, stability, and smarts. This is to help eliminate administrative tasks and workarounds, optimise the efficiency of clinical and administrative staff, and maximise profits.

Pro Medicus has been growing its earnings at a rapid rate over the last decade. And thanks to increasing demand for its technology from some of the biggest healthcare institutions in the world, it appears well-placed to continue this positive form for the foreseeable future. Goldman Sachs is a fan of the company and recently upgraded Pro Medicus’ shares to a buy rating with a $53.80 price target. The Pro Medicus share price last traded at $43.29.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd. The Motley Fool Australia has recommended Kogan.com ltd and Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 highly rated ASX growth shares to buy now appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!